A Retrospective Observational Cohort Study to Evaluate the Effectiveness of Azacitidine Monotherapy in Treatment-naive Patients With Intermediate, High, and Very High-risk Myelodysplastic Syndrome

01/12/2020
24/05/2024
EU PAS number:
EUPAS38242
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

GS-US-545-5956-appendix-16.1.1-protocol_f-redact

English (1.53 MB - PDF) View document
Study results
Study results

GS-US-545-5956-Synopsis_f-redact

English (1.07 MB - PDF) View document
Study report
Other information